Tianda Pharmaceuticals Ltd (455):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Tianda Pharmaceuticals Ltd (455) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11515
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:香港
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tianda Pharmaceuticals Ltd (Tianda Pharma), a subsidiary of Tianda Group Ltd, is a healthcare supplement product manufacturer that researches, develops, manufactures and markets biotechnology, pharmaceutical and health care products. The company provides products covering various therapeutic areas such as cardio-cerebrovascular drugs, pediatric drugs, anti-flu and respiratory drugs, anti-infective drugs, anti-diabetic drugs, anti-neoplastics drugs and detoxification drugs. Its cardio-cerebrovascular drugs comprise zhikang granules, cerebroprotein hydrolysate injection, valsartan capsules, aceglutamide injection, vinpocetine injection and aspirin enteric-coated tablets. Tianda Pharma also conducts research and development for vaccines and blood products. The company operates two research and development centers and production bases in Zhuhai and Kunming, China. It has operations in China and Australia. Tianda Pharma is headquartered in Hong Kong.

Tianda Pharmaceuticals Ltd (455) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tianda Pharmaceuticals Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Aslan Pharma Raises Additional USD9 Million in Venture Financing 11
Aslan Pharma Raises USD34 Million in Series C Financing 13
Equity Offering 15
Tianda Pharma to Raise USD14 Million in Private Placement of Shares 15
Acquisition 16
Tianda Pharma Acquires Cynergy Health, Consumr Healthcare Company 16
Tianda Pharmaceuticals Ltd – Key Competitors 17
Tianda Pharmaceuticals Ltd – Key Employees 18
Tianda Pharmaceuticals Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Jun 28, 2018: Tianda Pharmaceuticals: Annual Results Announcement for the Year Ended 31 March 2018 20
Nov 22, 2017: Tianda Pharmaceuticals: Interim Results For The Six Months Ended 30 September 2017 23
Corporate Communications 25
Dec 29, 2017: Tianda Pharmaceuticals Announces Resignation of non-executive director 25
Dec 27, 2017: Tianda Pharmaceuticals Announces Appointment of Non-executive Director 26
Jan 25, 2017: Tianda Pharmaceuticals: Change of Managing Director and Re-Designation of Director 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tianda Pharmaceuticals Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Tianda Pharmaceuticals Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Aslan Pharma Raises Additional USD9 Million in Venture Financing 11
Aslan Pharma Raises USD34 Million in Series C Financing 13
Tianda Pharma to Raise USD14 Million in Private Placement of Shares 15
Tianda Pharma Acquires Cynergy Health, Consumr Healthcare Company 16
Tianda Pharmaceuticals Ltd, Key Competitors 17
Tianda Pharmaceuticals Ltd, Key Employees 18
Tianda Pharmaceuticals Ltd, Other Locations 19

List of Figures
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tianda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tianda Pharmaceuticals Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Tianda Pharmaceuticals Ltd (455):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vietnam Export Import Commercial Joint Stock Bank:企業の戦略・SWOT・財務分析
    Vietnam Export Import Commercial Joint Stock Bank - Strategy, SWOT and Corporate Finance Report Summary Vietnam Export Import Commercial Joint Stock Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structur …
  • Malakoff Corporation Berhad:発電所・企業SWOT分析
    Malakoff Corporation Berhad - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key e …
  • La-Z-Boy Inc (LZB):企業の財務・戦略的SWOT分析
    La-Z-Boy Inc (LZB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • ViaCyte Inc-製薬・医療分野:企業M&A・提携分析
    Summary ViaCyte Inc (ViaCyte), formerly Novocell, Inc. is a regenerative medicine company that focuses on the development of cell replacement therapies for the treatment of diabetes. The company’s pipeline product portfolio includes VC-01, which is being developed as a therapy for T1D patients who h …
  • Dr. Paul Lohmann GmbH KG:企業の戦略・SWOT・財務情報
    Dr. Paul Lohmann GmbH KG - Strategy, SWOT and Corporate Finance Report Summary Dr. Paul Lohmann GmbH KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Altana AG:企業の戦略的SWOT分析
    Altana AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Vietnam Technological and Commercial Joint Stock Bank (TCB):企業の財務・戦略的SWOT分析
    Vietnam Technological and Commercial Joint Stock Bank (TCB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the comp …
  • Take-Two Interactive Software, Inc.:企業の戦略・SWOT・財務分析
    Take-Two Interactive Software, Inc. - Strategy, SWOT and Corporate Finance Report Summary Take-Two Interactive Software, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • China National Nuclear Power Co Ltd (601985):電力:M&Aディール及び事業提携情報
    Summary China National Nuclear Power Co Ltd (CNNPC), a subsidiary of China National Nuclear Corp is a nuclear energy company. The company provides activities such as development, investment, construction, operations and management of nuclear power projects and technical research in the safe operatio …
  • United Therapeutics Corporation:企業の戦略・SWOT・財務分析
    United Therapeutics Corporation - Strategy, SWOT and Corporate Finance Report Summary United Therapeutics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Valeura Energy Inc (VLE):企業の財務・戦略的SWOT分析
    Valeura Energy Inc (VLE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Bartlett Cocke General Contractors:企業の戦略・SWOT・財務情報
    Bartlett Cocke General Contractors - Strategy, SWOT and Corporate Finance Report Summary Bartlett Cocke General Contractors - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Astaldi S.p.A.:戦略・SWOT・企業財務分析
    Astaldi S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Astaldi S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Ctrip.Com International Ltd
    Ctrip.Com International Ltd - Strategy, SWOT and Corporate Finance Report Summary Ctrip.Com International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Barnes & Noble Education Inc (BNED):企業の財務・戦略的SWOT分析
    Barnes & Noble Education Inc (BNED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • University of Cambridge-医療機器分野:企業M&A・提携分析
    Summary University of Cambridge (UC) is an educational and research institute that offers undergraduate and graduate studies. The institute offers undergraduate courses in areas of architecture, chemical engineering, classics, computer science. It provides courses such as economics, education, engin …
  • Toyo Seikan Group Holdings, Ltd.
    Toyo Seikan Group Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Toyo Seikan Group Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Nichiha Corporation:企業の戦略・SWOT・財務情報
    Nichiha Corporation - Strategy, SWOT and Corporate Finance Report Summary Nichiha Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Dart Group PLC:企業の戦略・SWOT・財務情報
    Dart Group PLC - Strategy, SWOT and Corporate Finance Report Summary Dart Group PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • OPKO Health Inc (OPK):製薬・医療:M&Aディール及び事業提携情報
    Summary OPKO Health Inc (OPKO) discovers, develops, manufactures and commercializes novel diagnostic technologies and pharmaceuticals. The company’s product portfolio includes point-of-care tests, laboratory developed tests (LDTs), molecular diagnostics tests, and proprietary pharmaceuticals and vac …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆